参考文献/References:
[1] Martínez-Castelao A,Navarro-González JF,Górriz JL,et al.The concept and the epidemiology of diabetic nephropathy have changed in recent years[J].J Clin Med,2015,4(6):1207-1216.
[2] Zhang L,Long J,Jiang W,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9):905-906.
[3] 中华医学会糖尿病学分会微血管并发症学组.糖尿病肾病防治专家共识(2014年版)[J].中华糖尿病杂志,2014,6(11):792-801.
[4] Shoelson SE,Lee J,Goldfine AB.Inflammation and insulin resistance[J].J Clin Invest,2006,116(7):1793-1801.
[5] Stringhini S,Batty GD,Bovet P,et al.Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk:The whitehall Ⅱ prospective cohort study[J].PLoS Med,2013,10(7):e1001479.
[6] Pérez-Morales RE,Del-Pino MD,Valdivielso JM,et al.Inflammation in diabetic kidney disease[J].Nephron,2019,143(1):12-16.
[7] 胡 纯,吴小燕.糖尿病肾病炎症发生机制及治疗研究进展[J/OL].重庆医科大学学报:1-7[2021-02-22].https://doi.org/10.13406/j.cnki.cyxb.002672.
[8] Duman TT,Aktas G,Atak BM,et al.Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus[J].Afr Health Sci,2019,19(1):1602-1606.
[9] 朱志坚,孙丽芳,陆志刚.外周血中性粒细胞/淋巴细胞比值对急性心肌梗死患者预后的预测价值[J].陕西医学杂志,2019,48(10):1326-1329.
[10] 王 营,倪 虹.中性粒细胞淋巴细胞比值动态变化对卵巢癌预后的预测价值[J].陕西医学杂志,2020,49(2):197-200,204.
[11] Liu J,Liu X,Li Y,et al.The association of neutrophil to lymphocyte ratio,mean platelet volume,and platelet distribution width with diabetic retinopathy and nephropathy:A meta-analysis[J].Biosci Rep,2018,38(3):172.
[12] Fawwad A,Butt AM,Siddiqui IA,et al.Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes:Pakistan's perspective[J].Turk J Med Sci,2018,48(1):157-161.
[13] Kahraman C,Kahraman NK,Aras B,et al.The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients:A pilot study[J].Arch Med Sci,2016,12(3):571-575.
[14] Akbas EM,Demirtas L,Ozcicek A,et al.Association of epicardial adipose tissue,neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy[J].Int J Clin Exp Med,2014,7(7):1794-1801.
[15] 王英慧,徐 力.中性粒细胞/淋巴细胞比值与老年2型糖尿病肾病的相关性[J].中国老年学杂志,2018,38(15):3632-3633.
[16] 蔡宝石,李 玲,李 梅,等.血府逐瘀汤联合双胍类降糖药治疗糖尿病疗效研究[J].陕西中医,2020,41(6):774-776,789.
[17] Wang L,Gao P,Zhang M,et al.Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J].JAMA,2017,317(24):2515-2523.
[18] 倪永圣,王爱兰,晏文芬,等.中性粒细胞与淋巴细胞比值对诊断早期2型糖尿病肾病的价值分析[J].检验医学与临床,2020,17(11):1520-1523.
[19] 曹润泽,李雪锋.中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值、淋巴细胞/单核细胞比值与2型糖尿病肾病患者肾功能的相关性研究[J].临床内科杂志,2020,37(7):508-510.
[20] Assulyn T,Khamisy-Farah R,Nseir W,et al.Neutrophil-to-lymphocyte ratio and red blood cell distribution width as predictors of microalbuminuria in type 2 diabetes[J].J Clin Lab Anal,2020,34(7):e23259.
相似文献/References:
[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(6):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(6):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[7]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(6):1032.
[8]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(6):1163.
[9]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[10]张静雯,汪 宁,邱红霞,等.非布司他治疗早期糖尿病肾病合并高尿酸血症疗效及对患者肾功能影响研究*[J].陕西医学杂志,2020,49(2):209.
ZHANG Jingwen,WANG Ning,QIU Hongxia,et al.Efficacy of febuxostat on early diabetic nephropathy with hyperuricemia and its effect on renal function[J].,2020,49(6):209.
[11]薛海燕,李振江,孔令强.不同分期糖尿病肾病患者25羟维生素D、低氧诱导因子-1α检测及临床意义[J].陕西医学杂志,2021,50(5):614.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.025]
XUE Haiyan,LI Zhenjiang,KONG Lingqiang.Expression and significance of 25-hydroxyvitamin D and hypoxia-inducible factor-1α in patients with diabetic nephropathy in different stages[J].,2021,50(6):614.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.025]
[12]李 晶,屈 勇,YAROV(哈萨克斯坦).血浆可溶性CD146与2型糖尿病患者肾功能关系及对白蛋白尿短期进展的预测价值研究[J].陕西医学杂志,2023,52(3):282.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.008]
LI Jing,QU Yong,YAROV.Relationship between plasma soluble CD146 and renal function in patients with type 2 diabetes mellitus and its predictive value for short-term progression of albuminuria[J].,2023,52(6):282.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.008]